Literature DB >> 11578962

T cells in the pathogenesis of systemic lupus erythematosus.

R W Hoffman1.   

Abstract

The role of T cells in the pathogenesis of systemic lupus erythematosus (SLE) is reviewed with a focus on autoantigen-specific T cells in SLE. The initial clue to a role for T cells in SLE was histopathologic studies demonstrating extensive infiltration of T cells at the sites of inflammation. Later studies, showing association between HLA polymorphisms and specific autoantibodies, directly implicated a role for T cells in autoantibody production. More recently, we and others have identified and characterized autoantigen-specific T cells in SLE. We review these studies on the role of autoantigen-specific T cells in SLE and present new findings on the molecular characterization of T cell immunity to Sm-B, Sm-D and U1-70kD small nuclear ribonucleoprotein (snRNP) autoantigens.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11578962     DOI: 10.2741/hoffman

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  8 in total

1.  Model-based determination of abatacept exposure in support of the recommended dose for Japanese rheumatoid arthritis patients.

Authors:  Mayumi Hasegawa; Yasuhiko Imai; Masaki Hiraoka; Kiyomi Ito; Amit Roy
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-10-15       Impact factor: 2.745

Review 2.  Blockade of co-stimulation in chronic inflammatory diseases.

Authors:  Clemens Scheinecker
Journal:  Wien Med Wochenschr       Date:  2014-10-01

3.  CCR5Δ32 (rs333) polymorphism is associated with the susceptibility to systemic lupus erythematosus in female Brazilian patients.

Authors:  Thiago Hissnauer Leal Baltus; Ana Paula Kallaur; Marcell Alysson Batisti Lozovoy; Helena Kaminami Morimoto; Francieli Delongui; Daniela Frizon Alfieri; Tatiane Mayumi Veiga Iriyoda; Isaias Dichi; Andrea Name Colado Simão; Edna Maria Vissoci Reiche
Journal:  Rheumatol Int       Date:  2015-06-14       Impact factor: 2.631

4.  Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus.

Authors:  L C W Lit; C K Wong; L S Tam; E K M Li; C W K Lam
Journal:  Ann Rheum Dis       Date:  2005-06-23       Impact factor: 19.103

5.  CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus.

Authors:  M Mamtani; B Rovin; R Brey; J F Camargo; H Kulkarni; M Herrera; P Correa; S Holliday; J-M Anaya; S K Ahuja
Journal:  Ann Rheum Dis       Date:  2007-10-30       Impact factor: 19.103

Review 6.  Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus.

Authors:  Shui-Lian Yu; Woon-Pang Kuan; Chun-Kwok Wong; Edmund K Li; Lai-Shan Tam
Journal:  Clin Dev Immunol       Date:  2012-01-23

7.  Tolerogenic versus inflammatory activity of peripheral blood monocytes and dendritic cells subpopulations in systemic lupus erythematosus.

Authors:  Tiago Carvalheiro; Ana Rodrigues; Ana Lopes; Luís Inês; Isabel Velada; Andreia Ribeiro; António Martinho; José A P Silva; Maria L Pais; Artur Paiva
Journal:  Clin Dev Immunol       Date:  2012-08-30

8.  Case report for recurrent and new-onset SLE patients treated by high-dose glucocorticoid therapy: Characteristics of peripheral TCR beta chain CDR3 repertoires.

Authors:  Jiang Yu; Bin Shi; Long Ma; Chunmei Liu; Suhong Sun; Rui Ma; Yuehong Qiu; Xinsheng Yao
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.